1
|
Baek A, Coots L, Andersen E, Lele S, Juan H, Mountziaris P. Effect of Enhanced Recovery After Surgery (ERAS) on racial disparities in prescribing practices for autologous breast reconstruction. Clin Nutr ESPEN 2022. [DOI: 10.1016/j.clnesp.2022.06.039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
2
|
Andersen E, Juhl CR, Kjøller ET, Lundgren JR, Janus C, Saupstad M, Ingerslev LR, Jensen SBK, Holst JJ, Stallknecht BM, Madsbad S, Torekov SS, Barrès R. O-018 Sperm count is increased by diet-induced weight loss and maintained by exercise or GLP-1 analogue treatment: a randomised controlled trial. Hum Reprod 2022. [DOI: 10.1093/humrep/deac104.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Study question
Does diet-induced weight loss improve semen parameters, and are these possible improvements maintained with sustained weight loss?
Summary answer
An 8-week low-calorie diet-induced weight loss was associated with improved sperm count, which was maintained after one year in men who maintained weight loss.
What is known already
Obesity is associated with impaired semen parameters. Weight loss improves metabolic health in obesity, but there is a lack of knowledge on the acute and long-term effects of weight loss on semen parameters.
Study design, size, duration
This is a substudy of men with obesity enrolled in a randomised, controlled, double-blinded trial (the S-LITE trial). The trial was conducted between August 2016 and November 2019. A total of 56 men was included in the study and assigned to an initial 8-week low-calorie diet (800 kcal/day) followed by randomisation to 52 weeks of either: placebo, exercise training, and placebo (exercise), the GLP-1 analogue liraglutide (liraglutide) or liraglutide in combination with exercise training (combination).
Participants/materials, setting, methods
Inclusion criteria were men who delivered semen samples, 18 to 65 years of age and a body mass index between 32 to 43 kg/m2, but otherwise healthy. The study was carried out at Hvidovre Hospital and at the University of Copenhagen, and the participants were from the Greater Copenhagen Area. We assessed semen parameters, anthropometrics and collected blood samples before (T0) and after the 8-week low-calorie dietary intervention (T1) and after 52 weeks (T2).
Main results and the role of chance
The men lost on average 16.5 kg (95% CI: 15.2-17.8) bodyweight during the low-calorie diet, which increased sperm concentration 1.49 fold (95% CI: 1.18-1.88, P<0.01) and sperm count 1.41 fold (95% CI: 1.07-1.87, P<0.01). These improvements were maintained for 52 weeks in men who maintained the weight loss but not in men who regained weight. Semen volume, sperm motility and motile sperm count did not change.
Limitations, reasons for caution
The S-LITE trial was a randomised controlled trial of weight loss maintenance. Analysis of semen was preregistered to explore the effects of weight loss and weight loss maintenance on semen parameters. Due to the small sample size, definite inferences cannot be made.
Wider implications of the findings
This study shows that sperm concentration and sperm count were improved after a diet-induced weight loss in men with obesity. Our findings indicate that both liraglutide and exercise as weight maintenance strategies may be used to maintain the improvements in sperm concentration and count.
Trial registration number
H-16027082
Collapse
Affiliation(s)
- E Andersen
- Novo Nordisk Foundation Center for Basic Metabolic Research- Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen , Denmark
| | - C R Juhl
- Department of Biomedical Sciences- Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen , Denmark
| | - E T Kjøller
- Novo Nordisk Foundation Center for Basic Metabolic Research- Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen , Denmark
| | - J R Lundgren
- Department of Biomedical Sciences- Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen , Denmark
| | - C Janus
- Department of Biomedical Sciences- Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen , Denmark
| | - M Saupstad
- Novo Nordisk Foundation Center for Basic Metabolic Research- Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen , Denmark
| | - L R Ingerslev
- Novo Nordisk Foundation Center for Basic Metabolic Research- Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen , Denmark
| | - S B K Jensen
- Department of Biomedical Sciences- Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen , Denmark
| | - J J Holst
- Department of Biomedical Sciences- Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen , Denmark
| | - B M Stallknecht
- Department of Biomedical Sciences- Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen , Denmark
| | - S Madsbad
- Department of Endocrinology, Copenhagen University Hospital Hvidovre, Hvidovre , Denmark
| | - S S Torekov
- Department of Biomedical Sciences- Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen , Denmark
| | - R Barrès
- Novo Nordisk Foundation Center for Basic Metabolic Research- Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen , Denmark
| |
Collapse
|
3
|
Maroof S, Henkel R, Osmundson M, Andersen E, Lodge Y, Carroll M, Campbell A. P-038 Comparison of three methods of semen analysis: A novel at-home sperm test kit, a computer-assisted assessment and an embryologist. Hum Reprod 2022. [PMCID: PMC9384434 DOI: 10.1093/humrep/deac104.109] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Study question
How does computer-assisted semen analysis (CASA) (Lenshooke, LOGIXX) and at-home sperm testing (ExSeed) compare with manual methodology assessment of male fertility based on WHO criteria (5thEdition); a three-method comparison study.
Summary answer
All methods showed good agreement for concentration and limited agreement for motility highlighting the need for further development of alternatives to manual assessment.
What is known already
Several studies have shown good correlation between CASA systems and laboratory-based manual semen analysis, but only a few have carried out a three-way comparison study. One of which showed positive correlation with motility and concentration between a smartphone-based semen analysis and laboratory-based CASA system and positive correlation between concentration and motility between the smartphone-based CASA system and microscopic-based results. The at-home sperm test kit may play a role in motivating infertile males to visit clinics for early diagnosis and also reducing the need for multiple visits to the fertility clinic for repeat semen analyses.
Study design, size, duration
Fifty patients (between 29 and 56 years) attending a fertility clinic were included in the study between September 2021 to December 2021. Semen samples were split into 3 aliquots and evaluated using manual semen assessment (MSA) according to the WHO 5th Edition (2010) guidelines, the ExSeed Home Sperm Test (HST) and the LensHooke® X1 PRO Semen Quality Analyzer (CASA).
Participants/materials, setting, methods
The semen samples were collected from fifty participants at CARE Fertility Tunbridge Wells. The samples were placed in an incubator at 37°C for 30 minutes to liquefy. After liquefaction, sperm concentration, total motility, total motile sperm count (TMSC) and normal morphology were evaluated. Spearman’s Rank correlations (>0.7) and Chi-squared tests were used and the p-value < 0.05 was considered as statistically significant.
Main results and the role of chance
All variables were highly significantly (p < 0.0002) positively correlated between all 3 methods.
The greatest correlations were obtained for sperm concentration (CASA/HST: r = 0.826; MSA/HST: r = 0.870; MSA/CASA: r = 0.871) and TMSC (MSA/CASA: p = 0.792; CASA/HST: r = 0.800; MSA/HST: r = 0.854). Correlations for motility were markedly lower (MSA/HST: r = 0.611; CASA/HST: r = 0.717; MSA/LCASA: r = 0.750). The lowest correlation was found for morphology (MSA/CASA: r = 0.500). The HST device does not determine morphology.
As compared to MSA, using the HST device agreement for normal or low sperm concentration (≥15 × 106/mL or < 15 × 106/mL respectively) was identified in 84.3% of the cases, whereas 94.0% with CASA. The agreement between CASA and HST was 82.0%. For total motility ≥ or < 40%, the agreements were 68.0% (CASA/HST), 56.9% (MSA/HST) and 82.0% (MSA/CASA), respectively.
For the identification of patients with normal morphology >4%, the agreement between MSA and CASA was 30%.
Limitations, reasons for caution
The small sample size was 50 cases. The home testing device does not assess morphology. Furthermore, it is difficult to ascertain whether a consumer would carry out the analysis with this device with the same accuracy as an embryologist.
Wider implications of the findings
The need for repeated semen analyses, the effect of the COVID-19 pandemic and the discomfort some patients feel in a clinical setting, necessitate the need for evaluation of novel semen analysis approaches. These emerging technologies have potential to be more patient friendly, convenient and efficient than standard semen assessment methods.
Trial registration number
not applicable
Collapse
Affiliation(s)
- S Maroof
- CARE Fertility, Embryology , Tunbridge Wells, United Kingdom
| | - R Henkel
- Logixx Pharma, Scientific Research , London, United Kingdom
| | - M Osmundson
- Logixx Pharma, Business Development , London, United Kingdom
| | - E Andersen
- Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences , Copenhagen, Denmark
| | - Y Lodge
- CARE Fertility, Embryology , Tunbridge Wells, United Kingdom
| | - M Carroll
- Manchester Metropolitan University, Cellular Science , Manchester, United Kingdom
| | - A Campbell
- CARE Fertility, Embryology , Nottingham, United Kingdom
| |
Collapse
|
4
|
Zukauskaite R, Grau Eriksen J, Andersen E, Johansen J, Samsøe E, Long Krogh S, Overgaard J, Grau C, Rønn Hansen C. MO-0480 Risk of acute mucositis following an increase in high dose CTV1 in HNSCC patients. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)02374-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
5
|
Nowicka-Matus K, Friborg J, Hansen C, Andersen E, Bernsdorf M, Elstrøm U, Farhadi M, Grau C, Eriksen J, Johansen J, Nielsen M, Petersen J, Samsøe E, Sibolt P, Smulders B, Jensen K. OC-0089 Acute toxicities in proton therapy of head-neck cancer – a matched analysis of DAHANCA 35 pilot data. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)02465-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
6
|
Zhao J, Zoe L, Reich D, Chapin A, Clayton A, Clyde B, Cox J, Fulmer M, Hong B, Lamb A, Mani C, Pizzo L, Quigley D, Rushton P, Schultz R, Tidwell T, Wen T, Mendoza CZ, Andersen E. OP041: Implementation of 2019 ACMG technical standards for the interpretation and reporting of constitutional CNVs: Experiences from an academic reference laboratory. Genet Med 2022. [DOI: 10.1016/j.gim.2022.01.612] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
7
|
Hansen C, Friborg J, Skyt P, Smulders B, Sibolt P, Nielsen M, Samsøe E, Petersen J, Johansen J, Zukauskaite R, Andersen E, Andersen M, Farhadi M, Eriksen J, Overgaard J, Grau C, Jensen K. Photon-proton dose plan comparison in the pilot phase of the randomized clinical DAHANCA 35 trial. Phys Med 2021. [DOI: 10.1016/s1120-1797(22)00106-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
8
|
Lassen P, Huang S, Su J, O’Sullivan B, Waldron J, Andersen M, Primdahl H, Johansen J, Andrup Kristensen C, Andersen E, Eriksen J, Rønn Hansen C, Alsner J, Lilja-Fisher J, Bratman S, Ringash J, Kim J, Hope A, Spreafico A, de Almeida J, Xu W, Overgaard J. PH-0051 Outcomes after definitive (C)RT in HPV+ OPC: Largescale comparison of two population-based cohorts. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)07233-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
9
|
Zukauskaite R, Grau Eriksen J, Andersen E, Johansen J, Samsøe Hinsby E, Long Krogh S, Overgaard J, Grau C, Rønn Hansen C. OC-0516 Local control in HNSCC after introduction of geometric margins in DAHANCA radiotherapy guidelines. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)06942-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
10
|
Onofre J, Geenen L, Cox A, Van Der Auwera I, Willendrup F, Andersen E, Campo R, Dhont N, Ombelet W. Simplified sperm testing devices: a possible tool to overcome lack of accessibility and inconsistency in male factor infertility diagnosis. An opportunity for low- and middle- income countries. Facts Views Vis Obgyn 2021; 13:79-93. [PMID: 33889864 PMCID: PMC8051200 DOI: 10.52054/fvvo.13.1.011] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
Abstract
Background Manual semen assessment (MSA) is a key component in a male’s fertility assessment. Clinicians rely on it to make diagnostic and treatment decisions. When performed manually, this routine laboratory test is prone to variability due to human intervention which can lead to misdiagnosis and consequently over- or under- treatment. For standardisation, continuous training, quality control (QC) programs and pricy Computer-Assisted Sperm Analysis (CASA) systems have been proposed, yet, without resolving intra- and inter-laboratory variability. In response, promising simplified sperm testing devices, able to provide cost-effective point-of-care male infertility diagnosis are prospected as a plausible solution to resolve variability and increase access to sperm testing. Materials and methods A throughout literature research for semen testing, sperm analysis, smart-phone assisted semen analysis, ‘at-home’ semen testing, male infertility, infertility in developing countries, infertility in low- and middle-income countries (LMIC) and quantitative sperm analysis was performed. A total of 14 articles, specific to ‘at-home’ simplified sperm assessment, were included to treat the core subject. Results Continuous training and consistent QC, are sine qua none conditions to achieve accurate and comparable MSA. Compliance does not rule-out variability, nevertheless. Emerging simplified sperm assessment devices are an actual alternative to resolve the lack of standardisation and accessibility to sperm analysis. YO ® , SEEM ® , and ExSeed ® are commercially available, user-friendly smartphone-based devices which can accurately measure volume, sperm concentration (millions/ml) and total motile sperm count. More broadly, by cost-effectiveness, availability, accuracy and convenient application, these devices could effectively select patients for first-line artificial reproduction treatments such as intrauterine insemination. Conclusions Accuracy and cost-effectiveness make smart-phone based sperm testing devices a practical and realistic solution to overcome variability in MSA. Importantly, these tools represent an actual opportunity to standardise and improve male subfertility diagnosis and treatment, especially in LMIC. However, before clinical application is possible, guidelines, further testing with special attention on accuracy in washed sperm, availability, cost-benefit and reliability are required.
Collapse
Affiliation(s)
- J Onofre
- Genk Institute for Fertility Technology, Genk, Belgium.,Department of Obstetrics, Gynaecology and Infertility, Ziekenhuis Oost Limburg, Genk, Belgium
| | - L Geenen
- University of Hasselt, Faculty of Medicine and Life Sciences, Diepenbeek, Belgium
| | - A Cox
- Department of Obstetrics, Gynaecology and Infertility, Ziekenhuis Oost Limburg, Genk, Belgium
| | - I Van Der Auwera
- Department of Obstetrics, Gynaecology and Infertility, Ziekenhuis Oost Limburg, Genk, Belgium
| | | | | | - R Campo
- Genk Institute for Fertility Technology, Genk, Belgium.,Department of Obstetrics, Gynaecology and Infertility, Ziekenhuis Oost Limburg, Genk, Belgium
| | - N Dhont
- Genk Institute for Fertility Technology, Genk, Belgium.,Department of Obstetrics, Gynaecology and Infertility, Ziekenhuis Oost Limburg, Genk, Belgium
| | - W Ombelet
- Genk Institute for Fertility Technology, Genk, Belgium.,Department of Obstetrics, Gynaecology and Infertility, Ziekenhuis Oost Limburg, Genk, Belgium
| |
Collapse
|
11
|
Jensen K, Vogelius I, Andersen M, Overgaard J, Eriksen J, Farhadi M, Andersen E, Johansen J, Friborg J. PO-0798: Early mortality after radical radiotherapy in head and neck cancer. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)00815-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
12
|
Kaplan L, Hansen C, Jensen K, Friborg J, Samsøe E, Johansen J, Andersen M, Smulders B, Andersen E, Nielsen M, Eriksen J, Petersen J, Elstrøm U, Holm A, Skyt P, Vestergaard A, Lorenzen E, Nielsen M, Marseguerra R, Morthorst M, Grau C, Korreman S. OC-0107: Quantitative metrics to analyze variations and support best practices in head and neck dose plans. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)00133-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
13
|
Henjum S, Kjollesdal MKR, Flaaten MO, Andersen E, Hjellset VT, Morseth MS. Prevalence of type 2 diabetes and associated risk factors among Saharawi refugees in Algeria. Eur J Public Health 2020. [DOI: 10.1093/eurpub/ckaa165.200] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
The Saharawi refugees have been living in refugee camps in the Algerian desert since 1975 and are dependent on food aid. A double burden of malnutrition by the coexistence of undernutrition among children and overweight and obesity among adults has been observed in the Saharawi refugee camps. Limited knowledge about the prevalence of type 2 diabetes (T2D) and associated risk factors exists in this population. The aim of this study was, therefore, to address this gap in the literature.
Methods
A cross-sectional survey was carried out in five Saharawi refugee camps in Algeria in 2014. A total of 180 women and 175 men were included. HbA1c was used to assess the prevalence of T2D and prediabetes. The Finnish Diabetes Risk Score (FINDRISC) was used to estimate the risk of developing T2D. Multiple logistic regressions were performed to assess risk factors associated with T2D and prediabetes.
Results
Median (min, max) HbA1c among the Saharawi refugees was 35 (4, 135) mmol/mol. The prevalence of T2D and prediabetes was 7% and 10%, respectively. The prevalence of overweight and obesity combined was 45%, and higher in women than in men. According to FINDRISC, 9% of participants had high risk of developing diabetes and 10% had moderate risk. In adjusted models, significant predictors for T2D were age, waist circumference and having a first-degree relative with T2D. Significant predictors for prediabetes were age, body mass index (BMI), waist circumference and a history of high blood glucose.
Conclusions
We found moderate prevalence of diabetes and prediabetes and a relatively high prevalence of overweight and obesity among the Saharawi refugees, especially the women. Given the fragility of the Saharawi health care system, screening for diabetes should be conducted in a cost-effective manner and high-risk individuals should receive advice about lifestyle changes (e.g. diet and physical activity).
Key messages
We found moderate prevalence of diabetes and pre-diabetes among the Saharawi refugees, and a high proportion were classified as overweight or obese. In light of this, the rates of T2D are likely to increase in the near future. The Saharawi health authorities should pay attention to the increased risk of diabetes in this vulnerable population.
Collapse
Affiliation(s)
- S Henjum
- Public Health Nutrition, Oslo Metropolitan University, Oslo, Norway
| | - M K R Kjollesdal
- Health Services Research, Norwegian Institute of Public Health, Oslo, Norway
| | - M O Flaaten
- Public Health Nutrition, Oslo Metropolitan University, Oslo, Norway
| | - E Andersen
- Faculty of Humanities, Sports and Educational Science, University of South-Eastern Norway, Horten, Norway
| | - V T Hjellset
- Public Health Nutrition, Oslo Metropolitan University, Oslo, Norway
| | - M S Morseth
- Public Health Nutrition, Oslo Metropolitan University, Oslo, Norway
| |
Collapse
|
14
|
Jensen KH, Vogelius I, Kristensen CA, Andersen E, Overgaard J, Eriksen JG, Primdahl H, Johansen J, Farhadi M, Andersen M, Friborg J. Early Mortality after Radical Radiotherapy in Head and Neck Cancer - A Nationwide Analysis from the Danish Head and Neck Cancer Group (DAHANCA) Database. Clin Oncol (R Coll Radiol) 2020; 33:57-63. [PMID: 32698963 DOI: 10.1016/j.clon.2020.07.004] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2020] [Revised: 06/08/2020] [Accepted: 07/02/2020] [Indexed: 12/18/2022]
Abstract
AIMS Curative-intent radiotherapy (RT) or chemoradiation (CRT) of squamous cell carcinoma of the head and neck (HNSCC) produces high survival rates, but is associated with substantial toxicity. However, there are no commonly accepted quality metrics for early mortality in radiation oncology. To assess the applicability of early mortality as a clinical quality indicator, this study investigated the temporal distribution, risk factors and trends of 90- and 180-day overall and non-cancer mortality in a nationwide cohort of HNSCC patients treated with RT/CRT. MATERIALS AND METHODS Information on all HNSCC patients treated with curative-intent RT/CRT in Denmark between 2000 and 2017 was obtained from the national Danish Head and Neck Cancer Group clinical database. Deaths in patients with residual or recurrent disease after RT/CRT were classified as cancer-related. Possible risk factors were investigated using logistic regression analysis. RESULTS Data from 11 419 patients were extracted. In total, 90- and 180-day mortality risks were 3.1% and 7.1%, respectively. There was a uniform temporal distribution of 180-day mortality. In multivariable analysis, increasing age, stage, performance status, earlier treatment year and hypopharyngeal cancer were significantly associated with an increased risk (P < 0.05). Risk factor estimates were comparable for 90- versus 180-day mortality as well as for overall versus non-cancer mortality. Between 2000 and 2017 there was a significant decrease in 180-day mortality, which was driven by a reduction in cancer-related events. CONCLUSION The distribution of 180-day overall and non-cancer mortality did not indicate a well-defined early high-risk period. Moreover, risk factor estimates were highly similar across risk periods and groups. Taken together, our findings question the applicability of early mortality as a standard metric for treatment-associated toxicity.
Collapse
Affiliation(s)
- K H Jensen
- Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
| | - I Vogelius
- Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
| | - C A Kristensen
- Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
| | - E Andersen
- Department of Oncology, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark
| | - J Overgaard
- Department of Oncology, Aarhus University Hospital, Aarhus, Denmark
| | - J G Eriksen
- Department of Oncology, Aarhus University Hospital, Aarhus, Denmark
| | - H Primdahl
- Department of Oncology, Aarhus University Hospital, Aarhus, Denmark
| | - J Johansen
- Department of Oncology, Odense University Hospital, Odense, Denmark
| | - M Farhadi
- Department of Oncology, Zealand University Hospital, Zealand, Denmark
| | - M Andersen
- Department of Oncology, Aalborg University Hospital, Aalborg, Denmark
| | - J Friborg
- Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
| |
Collapse
|
15
|
Carlander A, Zamani M, Larsen C, Hellelstrup D, Agander T, Kiss K, Olsen C, Baandrup L, Nielsen F, Andersen E, Friborg J, Buchwald C. Survival and characteristics of 772 patients with oropharyngeal cancer and specific human papillomavirus genotypes: A Danish population-based study from 2011-2017. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2019.11.191] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
16
|
Wormgoor MEA, Indahl A, Andersen E, Egeland J. Effectiveness of Briefer Coping-Focused Psychotherapy for Common Mental Complaints on Work-Participation and Mental Health: A Pragmatic Randomized Trial with 2-Year Follow-Up. J Occup Rehabil 2020; 30:22-39. [PMID: 31222615 DOI: 10.1007/s10926-019-09841-6] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Purpose The aim of this study was to assess short and long-term effectiveness of brief coping-focused psychotherapy (Brief-PsT) compared with short-term psychotherapy (Short-PsT) on work-participation (WP) and mental health. Both treatments were preceded by group education. Methods All participants were on, or at risk of, sick leave due to common mental complaints. Patients were selected for inclusion in this study based on levels of self-reported symptoms ('some' or 'seriously affected') of anxiety and depression. They were randomized to Brief-PsT (n = 141) or Short-PsT with a more extended focus (n = 143). Primary outcome was the transition of WP-state from baseline to 3 months follow-up. In addition, WP at 12 and 24 months follow-up were assessed. The secondary outcome, clinical recovery rate (CR-rate) was obtained from the Beck Depression and Beck Anxiety Inventories, at 2-year follow-up. In addition, self-reported mental health symptom severity, self-efficacy, subjective health complaints and life satisfaction were assessed. Results At 3 months follow-up, the increase in WP was significantly greater in Brief-PsT than in Short-PsT (p = 0.039). At 3 months, 60% in Brief-PsT and 51% in Short-PsT was at work, partial or full. Thereafter, these differences diminished, 84% and 80% were at work at 2-year follow up. The 2-year follow-up of the secondary outcome measurements was completed by 53% in Brief-PsT and 57% in Short PsT. CR-rate was significantly greater in Brief-PsT compared with the Short-PsT (69% vs. 51%, p = 0.024). Furthermore, there was a greater reduction in the number of subjective health complaints in Brief-PsT (4.0 vs. 1.9 p = 0.012). All other measurements favoured Brief-PsT as well, but did not reach statistical significance. Conclusions Brief coping-focused psychotherapy added to group education for persons with depression or anxiety complaints seemed more effective in enhancing early work participation compared with additional short-term psychotherapy of standard duration with more extended focus. Clinical recovery rate and decline of comorbid subjective health complaints at 2-year follow-up were also in favour of the brief coping-focused program.
Collapse
Affiliation(s)
- M E A Wormgoor
- Division Physical Medicine and Rehabilitation, Vestfold Hospital Trust, Stavern, Norway.
| | - A Indahl
- Division Physical Medicine and Rehabilitation, Vestfold Hospital Trust, Stavern, Norway
| | - E Andersen
- Division of Mental Health & Addiction, Vestfold Hospital Trust, Tønsberg, Norway
| | - J Egeland
- Division of Mental Health & Addiction, Vestfold Hospital Trust, Tønsberg, Norway
- Department of Psychology, University of Oslo, Oslo, Norway
| |
Collapse
|
17
|
Lassen P, Huang S, Su J, O’Sullivan B, Waldron J, Andersen M, Primdahl H, Johansen J, Kristensen C, Andersen E, Alsner J, Lilja-Fischer J, Bratman S, Spreafico A, de Almeida J, Xu W, Overgaard J. Treatment Outcomes and Survival Following Primary (chemo) Radiotherapy in HPV+ Oropharynx Cancer: A Largescale Comparison of Two Institutions. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.1535] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
18
|
Riggs ER, Nelson T, Merz A, Ackley T, Bunke B, Collins CD, Collinson MN, Fan YS, Goodenberger ML, Golden DM, Haglund-Hazy L, Krgovic D, Lamb AN, Lewis Z, Li G, Liu Y, Meck J, Neufeld-Kaiser W, Runke CK, Sanmann JN, Stavropoulos DJ, Strong E, Su M, Tayeh MK, Kokalj Vokac N, Thorland EC, Andersen E, Martin CL. Copy number variant discrepancy resolution using the ClinGen dosage sensitivity map results in updated clinical interpretations in ClinVar. Hum Mutat 2019; 39:1650-1659. [PMID: 30095202 DOI: 10.1002/humu.23610] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2018] [Revised: 07/16/2018] [Accepted: 08/03/2018] [Indexed: 11/07/2022]
Abstract
Conflict resolution in genomic variant interpretation is a critical step toward improving patient care. Evaluating interpretation discrepancies in copy number variants (CNVs) typically involves assessing overlapping genomic content with focus on genes/regions that may be subject to dosage sensitivity (haploinsufficiency (HI) and/or triplosensitivity (TS)). CNVs containing dosage sensitive genes/regions are generally interpreted as "likely pathogenic" (LP) or "pathogenic" (P), and CNVs involving the same known dosage sensitive gene(s) should receive the same clinical interpretation. We compared the Clinical Genome Resource (ClinGen) Dosage Map, a publicly available resource documenting known HI and TS genes/regions, against germline, clinical CNV interpretations within the ClinVar database. We identified 251 CNVs overlapping known dosage sensitive genes/regions but not classified as LP or P; these were sent back to their original submitting laboratories for re-evaluation. Of 246 CNVs re-evaluated, an updated clinical classification was warranted in 157 cases (63.8%); no change was made to the current classification in 79 cases (32.1%); and 10 cases (4.1%) resulted in other types of updates to ClinVar records. This effort will add curated interpretation data into the public domain and allow laboratories to focus attention on more complex discrepancies.
Collapse
Affiliation(s)
- Erin R Riggs
- Autism & Developmental Medicine Institute, Geisinger, Danville, PA, USA
| | - Tristan Nelson
- Autism & Developmental Medicine Institute, Geisinger, Danville, PA, USA
| | - Andrew Merz
- Autism & Developmental Medicine Institute, Geisinger, Danville, PA, USA
| | - Todd Ackley
- Michigan Medical Genetics Laboratories (MMGL), University of Michigan, Ann Arbor, MI, USA
| | | | | | - Morag N Collinson
- Wessex Regional Genetics Laboratory, Salisbury NHS Foundation Trust, Salisbury, Wiltshire, UK
| | - Yao-Shan Fan
- University of Miami Miller School of Medicine, Miami, FL, USA
| | - McKinsey L Goodenberger
- Genomics Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
| | - Denae M Golden
- Human Genetics Laboratory, Munroe-Meyer Institute, University of Nebraska Medical Center, Omaha, NE, USA
| | - Linda Haglund-Hazy
- Michigan Medical Genetics Laboratories (MMGL), University of Michigan, Ann Arbor, MI, USA
| | - Danijela Krgovic
- University Medical Centre Maribor, Laboratory of Medical Genetics, Maribor, Slovenia.,Faculty of Medicine, University of Maribor, Maribor, Slovenia
| | - Allen N Lamb
- ARUP Laboratories, Salt Lake City, UT, USA.,University of Utah, Salt Lake City, UT, USA
| | - Zoe Lewis
- ARUP Laboratories, Salt Lake City, UT, USA
| | | | - Yajuan Liu
- Clinical Cytogenomics Laboratory, Department of Pathology, University of Washington School of Medicine, Seattle, WA, USA
| | | | - Whitney Neufeld-Kaiser
- Clinical Cytogenomics Laboratory, Department of Pathology, University of Washington School of Medicine, Seattle, WA, USA
| | - Cassandra K Runke
- Genomics Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
| | - Jennifer N Sanmann
- Human Genetics Laboratory, Munroe-Meyer Institute, University of Nebraska Medical Center, Omaha, NE, USA
| | | | - Emma Strong
- Genome Diagnostics, The Hospital for Sick Children, University of Toronto, Canada
| | - Meng Su
- University of Miami Miller School of Medicine, Miami, FL, USA
| | - Marwan K Tayeh
- Michigan Medical Genetics Laboratories (MMGL), University of Michigan, Ann Arbor, MI, USA
| | - Nadja Kokalj Vokac
- University Medical Centre Maribor, Laboratory of Medical Genetics, Maribor, Slovenia.,Faculty of Medicine, University of Maribor, Maribor, Slovenia
| | - Erik C Thorland
- Genomics Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
| | - Erica Andersen
- ARUP Laboratories, Salt Lake City, UT, USA.,University of Utah, Salt Lake City, UT, USA
| | - Christa L Martin
- Autism & Developmental Medicine Institute, Geisinger, Danville, PA, USA
| |
Collapse
|
19
|
Riggs E, Andersen E, Cherry A, Kantarci S, Kearney H, Patel A, Raca G, Ritter D, South S, Thorland E, Pineda-Alvarez D, Aradhya S, Martin CL. 28. Standards for the classification and reporting of constitutional copy number variants: A ClinGen/ACMG joint consensus recommendation. Cancer Genet 2019. [DOI: 10.1016/j.cancergen.2019.04.034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
20
|
Saksø M, Andersen E, Bentzen J, Andersen M, Johansen J, Overgaard J, Eriksen J. OC-0388 A prospective multicenter DAHANCA study of hyperfractionated accelerated RT for head and neck cancer. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)30808-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
21
|
Rasmussen JH, Grønhøj C, Håkansson K, Friborg J, Andersen E, Lelkaitis G, Klussmann JP, Wittekindt C, Wagner S, Vogelius IR, von Buchwald C. Risk profiling based on p16 and HPV DNA more accurately predicts location of disease relapse in patients with oropharyngeal squamous cell carcinoma. Ann Oncol 2019; 30:629-636. [PMID: 30657857 DOI: 10.1093/annonc/mdz010] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
Abstract
BACKGROUND In the era of precision medicine and HPV-related oropharyngeal squamous cell carcinoma (OPSCC), it is relevant to assess the risk of not only survival, but also the risk of local, regional, or distant treatment failure. The UICC 8th edition uses the surrogate marker p16 to stratify for HPV association but discordance between p16 status and HPV association has been shown. The purpose of this study was to develop a prognostic model to predict the risk of local, regional, and distant metastases and non-cancer-related death for patients with OPSCC, test the prognostic relevance of adding HPV DNA and p16 status, and validate the findings in an independent external dataset. PATIENTS AND METHODS Consecutive patients diagnosed with OPSCC and treated with curative radiotherapy with or without cisplatin in eastern Denmark from 2000 to 2014 were included. Characteristics included age, gender, TNM stage, smoking habits, performance status, and HPV status assessed with p16 and HPV DNA. The information was used to develop a prognostic model for first site of failure with four competing events: recurrence in T-, N-, and M-site, and death with no evidence of disease. RESULTS Overall 1243 patients were eligible for the analysis. A prognostic model with the four events was developed and externally validated in an independent dataset with a heterogeneously treated patient population from another institution. The individual prognostication from the competing risk analysis is displayed in a user friendly online tool (https://rasmussen.shinyapps.io/OPSCCmodelHPV_p16/). Replacing p16 status with the combined variable HPV/p16 status influenced the HR and patients with HPV-/p16+ had significantly higher HR of M-site recurrence than HPV+/p16+ with a HR = 2.56; CI [1.30; 5.02]; P = 0.006 (P = 0.013 in the validation cohort). CONCLUSION Patients with HPV-/p16+ have significantly higher risk of M-site recurrence and could potentially be relevant candidates for clinical trials testing systemic treatments in combination with conventional treatments.
Collapse
Affiliation(s)
- J H Rasmussen
- Departments of Otorhinolaryngology, Head and Neck Surgery and Audiology.
| | - C Grønhøj
- Departments of Otorhinolaryngology, Head and Neck Surgery and Audiology
| | - K Håkansson
- Oncology, Section of Radiotherapy, Rigshospitalet, University of Copenhagen, Copenhagen
| | - J Friborg
- Oncology, Section of Radiotherapy, Rigshospitalet, University of Copenhagen, Copenhagen
| | - E Andersen
- Department of Oncology, Herlev Hospital, University of Copenhagen, Copenhagen
| | - G Lelkaitis
- Department of Pathology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
| | - J P Klussmann
- Department of Otorhinolaryngology, Head and Neck Surgery, Medical Faculty, University of Cologne, Cologne
| | - C Wittekindt
- Department of Otorhinolaryngology, Head and Neck Surgery, University of Giessen, Giessen, Germany
| | - S Wagner
- Department of Otorhinolaryngology, Head and Neck Surgery, University of Giessen, Giessen, Germany
| | - I R Vogelius
- Oncology, Section of Radiotherapy, Rigshospitalet, University of Copenhagen, Copenhagen
| | - C von Buchwald
- Departments of Otorhinolaryngology, Head and Neck Surgery and Audiology
| |
Collapse
|
22
|
Andersen PS, Andersen E, Graversgaard M, Christensen AA, Vejre H, Dalgaard T. Using landscape scenarios to improve local nitrogen management and planning. J Environ Manage 2019; 232:523-530. [PMID: 30503898 DOI: 10.1016/j.jenvman.2018.11.023] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/25/2018] [Revised: 10/14/2018] [Accepted: 11/06/2018] [Indexed: 06/09/2023]
Abstract
Scenario-building is a widely used tool to initiate discussions on future land uses. In scenarios possible futures can be explored and peoples' ideas as well as societal trends can be visualized by the use of maps, pictures and figures. With focus on agricultural nitrogen management, and point of departure in the farmers' decisions-regarding fertilizer inputs, crop rotations, land use, and drainage, landscape scenarios are formulated based on local ideas for future nitrogen management and general prospects for local development. The key research question addressed in this paper is how landscape scenarios can guide farmers to improve nitrogen management in smaller catchments dominated by farming. Participatory modelling was used to develop landscape scenarios, depicting the change of nitrogen emission as a result of changes in landscape management and agricultural practices. In the development of the scenarios we used an ArcMap based tool combining statistical data, experimental knowledge, nitrate leaching modelling and input from local stakeholders on biophysical as well as land use and farm management issues. The scenarios presented are the result of a collaborative planning experiment within the frames of the dNmark research alliance on nitrogen. Three different types of scenarios are presented and discussed and their effects in terms of N reduction are estimated. The three scenarios were called: River valley set-aside, constructed wetlands, and land zonation. All the modelled scenarios are estimated to have a positive effect i.e. a reduction of the level of N leached to the root zone. Based on the experience gathered in the project, the feasibility of using scenarios for future environmental planning in the agricultural landscapes is discussed. Further, this is related to the current discussion in Denmark on geographically targeted nitrogen regulation. It is concluded that the co-creative approach to formulation of scenarios can be an effective way of increasing the knowledge and ownership of possible future solutions, however the cost associated with this planning approach is likely to substantially higher that more traditional planning approaches. Consequently, the estimated transactions costs should be weighed against the expected benefits in terms of more successful implementation.
Collapse
Affiliation(s)
- P S Andersen
- Department of Geosciences and Natural Resource Management, University of Copenhagen, DK-1958, Frederiksberg, Denmark.
| | - E Andersen
- Department of Geosciences and Natural Resource Management, University of Copenhagen, DK-1958, Frederiksberg, Denmark
| | - M Graversgaard
- Department of Agroecology, Aarhus University, DK-8830, Tjele, Denmark
| | - A A Christensen
- Department of Geosciences and Natural Resource Management, University of Copenhagen, DK-1958, Frederiksberg, Denmark
| | - H Vejre
- Department of Geosciences and Natural Resource Management, University of Copenhagen, DK-1958, Frederiksberg, Denmark
| | - T Dalgaard
- Department of Agroecology, Aarhus University, DK-8830, Tjele, Denmark
| |
Collapse
|
23
|
Zockle J, Chandler B, Delgado K, Quigley D, Toydemir R, Andersen E. 8. An evidence-based approach to guide IGH-based reflex testing for plasma cell neoplasms. Cancer Genet 2018. [DOI: 10.1016/j.cancergen.2018.04.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
24
|
Andersen E, Burnside R, Coe B, Conlin L, Herriges J, Higginbotham T, Hilton B, Jobanputra V, Kearney H, Ouyang K, Paulraj P, Riggs ER, Rowsey R, Speevak M, Thorland E, Zhang L, Martin CL. 28. Dosage sensitivity curation of recurrent copy number variant regions. Cancer Genet 2018. [DOI: 10.1016/j.cancergen.2018.04.031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
25
|
Samsøe E, Grau C, Johansen J, Andersen E, Petersen J, Jensen K, Smulders B, Friborg J, Sand H, Andersen M, Logadóttir A, Ujmajuridze Z, Hansen C. PO-0922: Implementation of swallowing organs in national radiotherapy guidelines for H&N cancer. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)31232-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
26
|
Zukauskaite R, Hansen C, Johansen J, Grau C, Samsøe E, Andersen E, Petersen J, Overgaard J, Eriksen J. PV-0430: Localisation of recurrences in the neck after IMRT for HNSCC in relation to the elective CTV. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)30740-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
27
|
Overgaard J, Hoff C, Hansen H, Specht L, Overgaard M, Lassen P, Andersen E, Johansen J, Andersen L, Evensen J, Alsner J, Grau C. OC-0536: Darbepoetin alfa and radiotherapy in the treatment of SCCHN – the DAHANCA 10 randomized trial. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)30846-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
28
|
van de Glind I, Bunn C, Gray CM, Hunt K, Andersen E, Jelsma J, Morgan H, Pereira H, Roberts G, Rooksby J, Røynesdal Ø, Silva M, Sorensen M, Treweek S, van Achterberg T, van der Ploeg H, van Nassau F, Nijhuis-van der Sanden M, Wyke S. The intervention process in the European Fans in Training (EuroFIT) trial: a mixed method protocol for evaluation. Trials 2017; 18:356. [PMID: 28750673 PMCID: PMC5531072 DOI: 10.1186/s13063-017-2095-0] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2016] [Accepted: 07/11/2017] [Indexed: 02/05/2023] Open
Abstract
BACKGROUND EuroFIT is a gender-sensitised, health and lifestyle program targeting physical activity, sedentary time and dietary behaviours in men. The delivery of the program in football clubs, led by the clubs' community coaches, is designed to both attract and engage men in lifestyle change through an interest in football or loyalty to the club they support. The EuroFIT program will be evaluated in a multicentre pragmatic randomised controlled trial (RCT), for which ~1000 overweight men, aged 30-65 years, will be recruited in 15 top professional football clubs in the Netherlands, Norway, Portugal and the UK. The process evaluation is designed to investigate how implementation within the RCT is achieved in the various football clubs and countries and the processes through which EuroFIT affects outcomes. METHODS This mixed methods evaluation is guided by the Medical Research Council (MRC) guidance for conducting process evaluations of complex interventions. Data will be collected in the intervention arm of the EuroFIT trial through: participant questionnaires (n = 500); attendance sheets and coach logs (n = 360); observations of sessions (n = 30); coach questionnaires (n = 30); usage logs from a novel device for self-monitoring physical activity and non-sedentary behaviour (SitFIT); an app-based game to promote social support for physical activity outside program sessions (MatchFIT); interviews with coaches (n = 15); football club representatives (n = 15); and focus groups with participants (n = 30). Written standard operating procedures are used to ensure quality and consistency in data collection and analysis across the participating countries. Data will be analysed thematically within datasets and overall synthesis of findings will address the processes through which the program is implemented in various countries and clubs and through which it affects outcomes, with careful attention to the context of the football club. DISCUSSION The process evaluation will provide a comprehensive account of what was necessary to implement the EuroFIT program in professional football clubs within a trial setting and how outcomes were affected by the program. This will allow us to re-appraise the program's conceptual base, optimise the program for post-trial implementation and roll out, and offer suggestions for the development and implementation of future initiatives to promote health and wellbeing through professional sports clubs. TRIAL REGISTRATION ISRCTN81935608 . Registered on 16 June 2015.
Collapse
Affiliation(s)
- I van de Glind
- Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare (IQ healthcare), Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands
| | - C Bunn
- Institute of Health and Wellbeing, College of Social Sciences, 27 Bute Gardens, University of Glasgow, Glasgow, G12 8RS, UK.
| | - C M Gray
- Institute of Health and Wellbeing, College of Social Sciences, 27 Bute Gardens, University of Glasgow, Glasgow, G12 8RS, UK
| | - K Hunt
- MRC/CSO Social and Public Health Sciences Unit, Institute of Health and Wellbeing, 200 Renfield St, University of Glasgow, Glasgow, G2 3QB, UK
| | - E Andersen
- Department of Coaching and Psychology, Norwegian School of Sport Sciences, Oslo, Norway
| | - J Jelsma
- Department of Public and Occupational Health, and EMGO Institute for Health and Care Research, VU University Medical Center, Van der Boechorststraat 7, Amsterdam, 1081 BT, The Netherlands
| | - H Morgan
- Health Services Research Unit, University of Aberdeen, Aberdeen, AB25 2ZD, UK
| | - H Pereira
- Interdisciplinary Center for the Study of Human Performance (CIPER), Faculty of Human Kinetics, University of Lisbon, Estrada da Costa, 1495-688, Cruz Quebrada, Portugal
| | - G Roberts
- Department of Coaching and Psychology, Norwegian School of Sport Sciences, Oslo, Norway
| | - J Rooksby
- School of Computing Science, University of Glasgow, Glasgow, G12 8RZ, UK
| | - Ø Røynesdal
- Department of Coaching and Psychology, Norwegian School of Sport Sciences, Oslo, Norway
| | - M Silva
- Interdisciplinary Center for the Study of Human Performance (CIPER), Faculty of Human Kinetics, University of Lisbon, Estrada da Costa, 1495-688, Cruz Quebrada, Portugal
| | - M Sorensen
- Department of Coaching and Psychology, Norwegian School of Sport Sciences, Oslo, Norway
| | - S Treweek
- Health Services Research Unit, University of Aberdeen, Aberdeen, AB25 2ZD, UK
| | - T van Achterberg
- KU Leuven, Department of Public Health and Primary Care, Academic Centre for Nursing and Midwifery, Leuven, Belgium
| | - H van der Ploeg
- Department of Public and Occupational Health, and EMGO Institute for Health and Care Research, VU University Medical Center, Van der Boechorststraat 7, Amsterdam, 1081 BT, The Netherlands
| | - F van Nassau
- Department of Public and Occupational Health, and EMGO Institute for Health and Care Research, VU University Medical Center, Van der Boechorststraat 7, Amsterdam, 1081 BT, The Netherlands
| | - M Nijhuis-van der Sanden
- Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare (IQ healthcare), Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands
| | - S Wyke
- Institute of Health and Wellbeing, College of Social Sciences, 27 Bute Gardens, University of Glasgow, Glasgow, G12 8RS, UK
| |
Collapse
|
29
|
Hansen C, Johansen J, Samsøe E, Andersen E, Petersen J, Jensen K, Sand H, Andersen L, Grau C. PO-0613: Effect of geometric GTV-CTV margins in national contouring guidelines. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)31050-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
30
|
Zukauskaite R, Hansen C, Brink C, Grau C, Samsøe E, Johansen J, Andersen E, Petersen J, Overgaard J, Eriksen J. OC-0329: Does margin matter? Distribution of locoregional failures after primary IMRT for Head & Neck cancer. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)30771-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
31
|
Engh J, Andersen E, Martinsen E, Egeland J, Holmen T, Bigseth T, Bang-Kittilsen G. Metabolic health in patients with schizophrenia – CVD risk in a Norwegian outpatient population. Eur Psychiatry 2017. [DOI: 10.1016/j.eurpsy.2017.01.1570] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
The mortality of schizophrenia patients is approximately twice that of the general population and there is a 20% reduction in life expectancy in this patient group. Cardiovascular disease (CVD) is responsible for as much as 50% of the excess mortality associated with schizophrenia. One important source of the high CVD prevalence is the cluster of metabolic characteristics defining the metabolic syndrome (MetS: 3 or more of the following features: abdominal obesity, high blood pressure, elevated levels of triglycerides and fasting glucose and low levels of high-density lipoproteins). Patients with schizophrenia seem to be undertreated for these vascular risk factors relative to the general population. More knowledge is needed concerning broadened risk factors of cardiovascular disease in a representative sample of schizophrenia patients. We conducted preliminary cross sectional analyses in a sample of 64 consecutive outpatients with schizophrenia with a mean age of 37 years consisting of 59% men, who were enrolled in a treatment study. All used antipsychotics, and 71% were smokers. We found that (percentage of patients under treatment for the respective somatic condition in parenthesis) 82% were overweight, 49% had hypertonia (17%), 24% hyperglycemia (3%), 48% hypertriglyceridemia and 13% hyperlipidemia (10% triglycerid or cholesterol lowering medication). Forty percent had metabolic syndrome compared to 11% in the normal population (Norway, age corrected). Additionally, estimates of insulin resistance will be conducted. We found that the prevalence of MetS components was high in outpatient schizophrenia. A substantial discrepancy was found between metabolic ill health and medication treatment of such conditions.Disclosure of interestThe authors have not supplied their declaration of competing interest.
Collapse
|
32
|
Giannopoulou C, Andersen E, Demeurisse C, Cimasoni G. Neutrophil Elastase and its Inhibitors in Human Gingival Crevicular Fluid during Experimental Gingivitis. J Dent Res 2016; 71:359-63. [PMID: 1372921 DOI: 10.1177/00220345920710020301] [Citation(s) in RCA: 68] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
The relative concentrations and absolute amounts of neutrophil elastase and its two inhibitors, α2-macroglobulin (α2-M) and alantitrypsin (α1-AT), were determined in gingival crevicular fluid (GCF) collected from six dental students who refrained from brushing the upper left or right quadrant during three weeks. Plaque and gingival indices and flow of GCF were measured before, during, and after the three weeks of no brushing. Functional elastase, representing the enzyme complexed with a2-M, was measured by use of a low-molecular-weight fluorogenic substrate. Elastolytic activity in GCF was also assayed by use of elastin as substrate. Antigenic elastase, representing the enzyme complexed with a 1-AT, as well as the inhibitors a2-M and al-AT were measured by ELISA. After three weeks of plaque accumulation, the concentrations of both functional and antigenic elastase increased by a factor of about 3, whereas the concentrations of the inhibitors increased in a much higher proportion. No free elastase could be detected in GCF, as evidenced by the Sephadex G-75 elution profile of GCF, by the negative results obtained when elastin was used as substrate, and by the demonstration that pure enzyme kept its activity against the low-molecular-weight substrate after being saturated by a2-M.
Collapse
Affiliation(s)
- C Giannopoulou
- Division of Physiopathology and Periodontology, School of Dentistry, Medical Faculty, University of Geneva, Switzerland
| | | | | | | |
Collapse
|
33
|
Wulff NB, Kristensen CA, Andersen E, Charabi B, Sørensen CH, Homøe P. Risk factors for postoperative complications after total laryngectomy following radiotherapy or chemoradiation: a 10-year retrospective longitudinal study in Eastern Denmark. Clin Otolaryngol 2016; 40:662-71. [PMID: 25891761 DOI: 10.1111/coa.12443] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/11/2015] [Indexed: 12/11/2022]
Abstract
OBJECTIVES To determine the rates of and risk factors for postoperative complications following total laryngectomy in patients treated with radiotherapy or chemoradiation. DESIGN Retrospective longitudinal study. SETTING Tertiary medical centres. PARTICIPANTS A total of 143 patients undergoing total laryngectomy for squamous cell carcinoma of the larynx or hypopharynx. MAIN OUTCOME MEASURES Overall postoperative complications and fistula formation. RESULTS Overall postoperative complications, fistula formation, wound infection, bleeding and wound necrosis within one year after total laryngectomy occurred in 56.6%, 42.3%, 31.0%, 11.3% and 9.2% of patients, respectively. Stenosis of the pharynx/oesophagus and stoma shrinkage within five years after surgery were each seen in 18.2% of cases. In 66.7% of cases, conservative treatment of the fistulas was chosen. Rehospitalisations within five years occurred for 44.8% with a median rate of 1.5 (range 1-11). Smoking status (P = 0.005 and 0.013) and chronic obstructive pulmonary disease (COPD) (P = 0.013 and 0.011) were significant risk factors for both overall postoperative complications and fistula formation in uni- and multivariate analysis. Tumour localisation in the hypopharynx was associated with overall postoperative complications (P = 0.036). Residual tumour or cancer recurrence was associated with late-onset fistulas (P < 0.001). CONCLUSION The frequencies of postoperative complications after total laryngectomy were comparable with similar international studies, although fistula formation rate is increasing in Denmark. We suggest optimising treatment of COPD and to further encourage to smoking cessation. We propose that development of fistulas >2 months after surgery prompts immediate biopsies. Additionally, we suggest standardised registration of surgical techniques to identify variables affecting the frequency of postoperative complications.
Collapse
Affiliation(s)
- N B Wulff
- Department of Otolaryngology, Head & Neck Surgery and Audiology, Rigshospitalet, University Hospital of Copenhagen, Denmark
| | - C A Kristensen
- Department of Oncology, Rigshospitalet, University Hospital of Copenhagen, Denmark
| | - E Andersen
- Department of Oncology, Herlev Hospital, University Hospital of Copenhagen, Denmark
| | - B Charabi
- Department of Otolaryngology, Head & Neck Surgery and Audiology, Rigshospitalet, University Hospital of Copenhagen, Denmark
| | - C H Sørensen
- Department of Otolaryngology, Head & Neck Surgery and Audiology, Rigshospitalet, University Hospital of Copenhagen, Denmark
| | - P Homøe
- Department of Otolaryngology, Head & Neck Surgery and Audiology, Rigshospitalet, University Hospital of Copenhagen, Denmark.,Department of Otorhinolaryngology and Maxillofacial Surgery, Køge University Hospital, Denmark
| |
Collapse
|
34
|
Cabrera M, Ravenscroft G, Andersen E, McLean C, Azmanov D, Stark Z, Davis M, Kornberg A, Ryan M, Laing N. Severe autosomal recessive congenital hypomyelinating neuropathy causing death in the first four months of life. Neuromuscul Disord 2016. [DOI: 10.1016/j.nmd.2016.06.200] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
35
|
Wulff N, Andersen E, Kristensen C, Sørensen C, Charabi B, Homøe P. Prognostic factors for survival after salvage total laryngectomy following radiotherapy or chemoradiation failure: a 10-year retrospective longitudinal study in eastern Denmark. Clin Otolaryngol 2016; 42:336-346. [DOI: 10.1111/coa.12726] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/15/2016] [Indexed: 12/15/2022]
Affiliation(s)
- N.B. Wulff
- Department of Otolaryngology, Head & Neck Surgery and Audiology; Rigshospitalet; University Hospital of Copenhagen; Copenhagen
| | - E. Andersen
- Department of Oncology; Herlev Hospital; University Hospital of Copenhagen; Herlev
| | - C.A. Kristensen
- Department of Oncology; Rigshospitalet; University Hospital of Copenhagen; Copenhagen
| | - C.H. Sørensen
- Department of Otolaryngology, Head & Neck Surgery and Audiology; Rigshospitalet; University Hospital of Copenhagen; Copenhagen
| | - B. Charabi
- Department of Otolaryngology, Head & Neck Surgery and Audiology; Rigshospitalet; University Hospital of Copenhagen; Copenhagen
| | - P. Homøe
- Department of Otolaryngology, Head & Neck Surgery and Audiology; Rigshospitalet; University Hospital of Copenhagen; Copenhagen
- Department of Otorhinolaryngology and Maxillofacial Surgery; Zealand University Hospital; Køge
| |
Collapse
|
36
|
Engstroem K, Casares-Magaz O, Roervik J, Andersen E, Muren L. WE-AB-202-12: Voxel-Wise Analysis of Apparent Diffusion Coefficient and Perfusion Maps in Multi-Parametric MRI of Prostate Cancer. Med Phys 2016. [DOI: 10.1118/1.4957753] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
37
|
Lyhne N, Primdahl H, Kristensen C, Andersen E, Johansen J, Andersen L, Overgaard J. OC-0449: Pattern of failure and disease control in patients treated for glottic cancer in Denmark 1971-2011. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)31698-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
38
|
Samsøe E, Andersen E, Hansen C, Johansen J, Sand H, Andersen L, Petersen J, Jensen K, Smulders B, Kristensen C, Grau C. PO-0944: Radiotherapy QA of the DAHANCA 19 protocol. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)40936-3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
39
|
Møller P, Primdahl H, Kristensen C, Andersen E, Andersen L, Overgaard J, Johansen J. PO-1129 Effect of continued tobacco smoking during radiotherapy on loco-regional control for carcinoma of the larynx. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)41121-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
40
|
Hermanrud T, Farhadi M, Boje C, Madsen C, Nowicka-Matus K, Johansen J, Andersen E, Primdahl H, Andersen M, Friborg J. OC-040: Hypopharynx carcinoma - the influence of IMRT and concurrent chemotherapy. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)34800-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
41
|
Friborg J, Farhadi M, Boye C, Madsen C, Pedersen M, Nowicka-Matus K, Johansen J, Andersen E, Primdahl H, Andersen L, Hermanrud T. Locoregional Control and Survival After Primary Radiation Therapy of Hypopharyngeal Carcinoma: A Population-Based Study. Int J Radiat Oncol Biol Phys 2014. [DOI: 10.1016/j.ijrobp.2014.05.1639] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
42
|
Maare C, Kjeldsen R, Jensen K, Andersen M, Andersen E, Johansen J. PO-0666: High dose hypofractionated radiotherapy for treatment and palliation of head and neck cancer patients. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)30784-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
43
|
Samsøe E, Andersen E, Hansen C, Johansen J, Sand H, Andersen L, Petersen J, Jensen K, Brink C, Grau C. PO-0930: From random sampling QA to digital central review QA of multicentre clinical H&N radiotherapy protocols in DAHANCA. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)31048-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
44
|
Bøje C, Dalton S, Primdahl H, Kristensen C, Andersen E, Johansen J, Andersen L, Overgaard J. OC-0061: Evaluation of comorbidity in 9,388 Head and Neck Cancer patients: A study from the DAHANCA database. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)30166-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
45
|
Lyhne N, Primdahl H, Kristensen C, Andersen E, Johansen J, Andersen L, Evensen J, Overgaard J. OC-0056: The DAHANCA 6 randomised trial: Five versus six fractions per week of radiotherapy in glottic cancer. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)30161-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
46
|
Andersen E, Rácz I, Erös A, Bánhegyi G, Fenyvesi É, Takács E. Development of synthetic and natural mineral based adsorptive and filter media containing cyclodextrin moieties. ACTA ACUST UNITED AC 2013. [DOI: 10.1088/1757-899x/47/1/012038] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
47
|
Andersen E, Kallehauge J, Jurgenliemk-Schulz I, Tanderup K, Lyng H, Malinen E. PO-0862: Cross-institutional comparison of pharmacokinetic parameters from DCEMRI of cervical cancers: initial results. Radiother Oncol 2013. [DOI: 10.1016/s0167-8140(15)33168-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
48
|
Lyhne NM, Christensen A, Alanin MC, Bruun MT, Jung TH, Bruhn MA, Jespersen JBB, Kristensen CA, Andersen E, Godballe C, Buchwald C, Bundgaard T, Johansen J, Lambertsen K, Primdahl H, Toustrup K, Sørensen JA, Overgaard J, Grau C. Waiting times for diagnosis and treatment of head and neck cancer in Denmark in 2010 compared to 1992 and 2002. Eur J Cancer 2012; 49:1627-33. [PMID: 23274198 DOI: 10.1016/j.ejca.2012.11.034] [Citation(s) in RCA: 55] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2012] [Revised: 11/12/2012] [Accepted: 11/21/2012] [Indexed: 11/24/2022]
Abstract
BACKGROUND AND AIM Significant tumour progression was observed during waiting time for treatment of head and neck cancer. To reduce waiting times, a Danish national policy of fast track accelerated clinical pathways was introduced in 2007. This study describes changes in waiting time and the potential influence of fast track by comparing waiting times in 2010 to 2002 and 1992. METHODS Charts of all new patients diagnosed with squamous cell carcinoma of the oral cavity, pharynx and larynx at the five Danish head and neck oncology centres from January to April 2010 (n=253) were reviewed and compared to similar data from 2002 (n=211) and 1992 (n=168). RESULTS The median time to diagnosis was 13 days (2010) versus 17 days (2002; p<0.001) and 20 days (1992; p<0.001). Median days from diagnosis to treatment start were 25 (2010) versus 47 (2002; p<0.001) and 31 (1992; p<0.001). Total pre-treatment time was median 41 days in 2010 versus 69 days (2002) (p<0.001) and 50 days (1992; p<0.001). Significantly more diagnostic imaging was done in 2010 compared to 2002 and 1992. When compared to current fast track standards the adherence to diagnosis improved slightly from 47% (1992) to 51% (2002) and 64% (2010); waiting time for radiotherapy was within standards for 7%, 1% and 22% of cases, respectively; waiting time for surgery was within standards for 17%, 22% and 48%, respectively. CONCLUSION The study showed a significant reduction in delay of diagnosis and treatment of head and neck cancer in 2010, but still less than half of all patients start treatment within the current standards.
Collapse
Affiliation(s)
- N M Lyhne
- Department of Oncology, Aarhus University Hospital, Denmark.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Andersen E, Hole K, Lund K, Kristensen G, Lyng H, Malinen E. OC-0187 IMPACT OF TUMOR DELINEATION ERRORS ON OUTCOME PREDICTION BASED ON DCE-MRI OF CERVICAL CANCER PATIENTS RECEIVING RT. Radiother Oncol 2012. [DOI: 10.1016/s0167-8140(12)70526-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
50
|
Lassen P, Primdahl H, Johansen J, Kristensen C, Andersen E, Andersen L, Evensen J, Overgaard J. OC-0149 HPV, SMOKING AND RT-OUTCOME IN ADVANCED OPC TREATED WITHOUT CHEMOTHERAPY – ANALYSIS OF DAHANCA PATIENTS. Radiother Oncol 2012. [DOI: 10.1016/s0167-8140(12)70488-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|